Lantheus Holdings Inc
NASDAQ:LNTH

  • LAST PRICE
    81.0700
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    56.4900/ 1
  • Ask / Lots
    82.0000/ 2
  • Open / Previous Close
    0.0000 / 81.0700
  • Day Range
    ---
  • 52 Week Range
    50.2000
    94.4700
  • Volume
    10

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Medical Equipment, Supplies & Distribution Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
LNTH
Lantheus Holdings Inc
5.5B
12.4x
+35.30%
STVN
Stevanato Group SpA
5.6B
32.9x
---
MMSI
Merit Medical Systems Inc
4.8B
47.2x
+14.05%
HAE
Haemonetics Corp
4.4B
36.5x
+17.09%
GKOS
Glaukos Corp
5.7B
-39.3x
---
INSP
Inspire Medical Systems Inc
4.8B
-307.8x
---
As of 2024-06-12

Company Information

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company. The Company is engaged in delivering science to enable clinicians to find, fight and follow disease to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Its Radiopharmaceutical Oncology diagnostics and therapeutic candidates help healthcare professionals (HCPs) find, fight, and follow cancer, with a focus in prostate cancer. Its Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Its Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma solutions platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, NEUROLITE, Xenon-133, CARDIOLITE, RELISTOR, Automated Bone Scan Index, and others. Its commercial products are used by cardiologists, internal medicine physicians, and others.

Contact Information

Headquarters
331 Treble Cove RdNORTH BILLERICA, MA, United States 01862
Phone
978-671-8001
Fax
302-636-5454

Executives

Chairman of the Board
Mary Heino
President
Paul Blanchfield
Chief Executive Officer, Director
Brian Markison
Chief Financial Officer, Treasurer
Robert Marshall
Chief Administrative Officer, General Counsel, Corporate Secretary
Daniel Niedzwiecki

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$5.5B
Revenue (TTM)
$1.4B
Shares Outstanding
69.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.52
EPS
$6.55
Book Value
$11.91
P/E Ratio
12.4x
Price/Sales (TTM)
4.0
Price/Cash Flow (TTM)
10.5x
Operating Margin
35.19%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.